Delivery Order SPE2DB20D3103-SPE2DB22FM9R8
- Not listed
- This federal contract award, valued at $1,212.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,557,309 units of Lisinopril 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 6, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,042.77, is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in 90-count bottles. The award is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets. The contract has a ceiling value of $2,069.52 and an ultimate completion date of April 25, 2023. The contract is a Delivery Order under the firm fixed price pricing type. It is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count sizes. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.61 fixed-price delivery order contract is for the supply of LISINOPRIL-HCTZ 20-25 MG TAB 500S, a cardiovascular medication. The contract has an ultimate completion date of March 12, 2025 and is not designated with any set-aside requirements. This award is associated with a larger Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $6,918.57, is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in quantities of 500. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- This federal contract award, with a value of $12,344.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,605,288 Lisinopril 10 mg tablets, a common blood pressure medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 15, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $5,641.31, is for the supply of 1,000 tablets of 40mg Lisinopril, a cardiovascular medication. The contract has no set-aside designation, indicating open competition. The parent company, Cencora, Inc., holds a significant $999,999,999 IDC with the DLA...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,684.67, is for the delivery of 4,563,947,551 units of the pharmaceutical product Lisinopril-HCTZ 10-12.5 mg tablets. This order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,819.20 by the Defense Logistics Agency (DLA) on January 8, 2026, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be completed by January 9, 2026, at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM9R8Delivery Order
This federal contract award, valued at $1,166.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lisinopril-HCTZ 20-25 mg tablets, a cardiovascular medication. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This specific delivery order has a completion date of March 11, 2022. The contract was awarded on a full and open basis without any set-aside requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/10/22 |